Associate Director / Director, Accounting and SEC Reporting
Lexeo TherapeuticsNew York, New York, United States
Posted March 19, 2026
150000 - 213000 USD
Full Time
About the Company
Lexeo Therapeutics is a New York‑based clinical‑stage genetic medicines company that applies pioneering science to fundamentally change disease treatment. Leveraging research from Weill Cornell Medicine and UC San Diego, the company partners with leading gene‑therapy institutions and follows a stepwise development strategy to advance a pipeline focused on cardiovascular disease and APOE4‑associated Alzheimer’s disease. Early proof‑of‑concept functional and biomarker data guide each program, while a leadership team of pioneers brings decades of experience in genetic medicines, rare‑disease drug development, manufacturing and commercialization. Lexeo’s distinctive combination of cutting‑edge science, strategic collaborations, and seasoned expertise positions it to accelerate the translation of gene‑based therapies into clinical reality.
Job Description
Reporting to Lexeo's Vice President and Corporate Controller, the Director, Accounting, will be responsible for the overall accounting and SEC reporting activities of the Company in addition to driving process improvements and support of accounting policies, procedures and internal controls. This hands-on role will oversee a team of two, execute day-to-day accounting functions, and produce high-quality SEC reporting while ensuring the application of best practices and compliance with all policies and internal controls.
Requirements
- 10+ years of progressive accounting experience in the biotechnology industry
- Bachelor’s degree in Accounting or related field; CPA preferred
- Public accounting experience at a Big 4 firm preferred
- Advanced Excel skills (modeling, pivot tables, VLOOKUPs)
- Prior experience mentoring and leading teams
Benefits
- Generous Paid Time Off
- 401k Matching
- Retirement Plan
- Relocation Assistance
